Matches in SemOpenAlex for { <https://semopenalex.org/work/W33072371> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W33072371 abstract "Biopharmaceuticals represent a growing share of drug innovation. These complex biological products are derived from recombinant DNA biotechnology and are defined by their manufacturing process. Copies of these products, called biosimilars, are not identical to their princeps products and complicate the treatment choice. Minimal changes at any stage of the biopharmaceutical manufacturing process may affect safety and/or efficacy. Cases illustrating the issues surrounding the optimization of biopharmaceutical safety and efficacy include:--the biological activity and immunogenicity of erythropoietins, which depend on the expression cell system and isoform,--glucocerebrosidases with non identical structures have the same bioactivity,--interchangeability of botulinum toxins,--pharmacokinetics of insulin analogs,--protein immunogenicity. The development and interchangeability of biopharmaceuticals must be addressed on a case-by-case basis. The European authorities propose guidelines for the development and registration of biological products, with a specific approach for biosimilars. Biopharmaceutical use requires close patient monitoring and product traceability." @default.
- W33072371 created "2016-06-24" @default.
- W33072371 creator A5022164931 @default.
- W33072371 date "2011-03-01" @default.
- W33072371 modified "2023-09-26" @default.
- W33072371 title "Comment sécuriser les traitements par les biomédicaments?" @default.
- W33072371 cites W137279778 @default.
- W33072371 cites W1977983409 @default.
- W33072371 cites W1985296111 @default.
- W33072371 cites W1985686555 @default.
- W33072371 cites W2014022336 @default.
- W33072371 cites W2025122282 @default.
- W33072371 cites W2046229867 @default.
- W33072371 cites W2083175767 @default.
- W33072371 cites W2086437884 @default.
- W33072371 cites W2095561478 @default.
- W33072371 cites W2121437343 @default.
- W33072371 cites W2145225963 @default.
- W33072371 cites W2153531851 @default.
- W33072371 cites W2911798554 @default.
- W33072371 cites W43762493 @default.
- W33072371 doi "https://doi.org/10.1016/s0001-4079(19)32073-4" @default.
- W33072371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22292313" @default.
- W33072371 hasPublicationYear "2011" @default.
- W33072371 type Work @default.
- W33072371 sameAs 33072371 @default.
- W33072371 citedByCount "0" @default.
- W33072371 crossrefType "journal-article" @default.
- W33072371 hasAuthorship W33072371A5022164931 @default.
- W33072371 hasConcept C138885662 @default.
- W33072371 hasConcept C150903083 @default.
- W33072371 hasConcept C15708023 @default.
- W33072371 hasConcept C17744445 @default.
- W33072371 hasConcept C2781047461 @default.
- W33072371 hasConcept C29456083 @default.
- W33072371 hasConcept C71924100 @default.
- W33072371 hasConcept C86803240 @default.
- W33072371 hasConceptScore W33072371C138885662 @default.
- W33072371 hasConceptScore W33072371C150903083 @default.
- W33072371 hasConceptScore W33072371C15708023 @default.
- W33072371 hasConceptScore W33072371C17744445 @default.
- W33072371 hasConceptScore W33072371C2781047461 @default.
- W33072371 hasConceptScore W33072371C29456083 @default.
- W33072371 hasConceptScore W33072371C71924100 @default.
- W33072371 hasConceptScore W33072371C86803240 @default.
- W33072371 hasLocation W330723711 @default.
- W33072371 hasLocation W330723712 @default.
- W33072371 hasOpenAccess W33072371 @default.
- W33072371 hasPrimaryLocation W330723711 @default.
- W33072371 isParatext "false" @default.
- W33072371 isRetracted "false" @default.
- W33072371 magId "33072371" @default.
- W33072371 workType "article" @default.